Why the study?
Does intracardiac impedance recording by implanted pacemakers correlate with tissue Doppler echocardiography for non-invasive assessment of the force-frequency relationship in patients with normal heart function?
Does intracardiac impedance recording by implanted pacemakers correlate with tissue Doppler echocardiography for non-invasive assessment of the force-frequency relationship in patients with normal heart function?
Intracardiac impedance measurements from permanent pacemakers can feasibly monitor force-frequency relationship changes, offering a potential non-invasive method for monitoring myocardial disease.
Pacemaker impedance-IVA correlation supports feasibility for force-frequency monitoring; leaves open utility in disease or practice change.
AIMS: In the normal heart, myocardial contractility is augmented at elevated heart rates. This effect is known as force-frequency relationship (FFR). The FFR is altered in failing hearts and may be used to detect myocardial function impairment. Force-frequency relationship measurements usually require invasive techniques and have therefore rarely been used in clinical practice. We studied the feasibility of FFR determination by implanted pacemakers as a non-invasive method in pacemaker patients. METHODS AND RESULTS: During follow-up visits in 30 patients with implanted pacemakers and normal heart function, the intracardiac impedance (IZ) was recorded by the pacemaker during incremental pacing at 80, 100, and 120 bpm. The time interval between the ventricular pacing pulse and IZmax (tIZm) and the maximum acceleration of the IZ change during myocardial contraction (IZacc: d2Z/dt2 max) were determined. Isovolumetric acceleration (IVA) was measured in parallel by tissue Doppler echocardiography at the right free wall, the left free wall, and the septum. With increasing pacing rates, the time interval tIZm shortened significantly and maximum acceleration IZacc increased significantly, consistent with the FFR. The best correlation was achieved between IZacc and IVA septal. CONCLUSION: Permanent pacemakers offering intracardiac IZ measurements can be used for monitoring FFR changes and, possibly, for low-effort first-line monitoring of myocardial disease.
No takes yet. Share an insight, caveat, or question.
Bondke et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: